Literature DB >> 33791139

Atypical Sjögren's Syndrome Initially Presenting as Lymphocytic Interstitial Pneumonitis followed by Immune Thrombocytopenia.

Maham Mehmood1, Abhishrut Jog1, Masooma Niazi2, Arlene Tieng1,3, Giovanni Franchin1,4.   

Abstract

BACKGROUND: Sjögren's syndrome is an autoimmune disease characterized primarily by decreased exocrine gland function leading to eye and mouth dryness. Extraglandular manifestations occur less frequently. Case Report. A 74-year-old man with hypertension was admitted with productive cough and fever. On physical examination, he had bilateral lower lung decreased breath sounds. A chest radiograph showed bibasilar patchy infiltrate. Laboratory studies revealed hemoglobin of 11.9 g/dL, white blood cell count of 16,000/uL, and platelet count of 250,000/uL. Empiric antibiotic therapy was begun for suspected community acquired pneumonia, and then he was discharged home. However, his cough recurred. Chest computed tomography demonstrated adenopathy throughout the mediastinum and multiple ill-defined patchy groundglass opacities with a lower lobe prominence. He underwent a transbronchial biopsy to rule out malignancy; however, it showed lymphocytic interstitial pneumonitis. Antinuclear antibody was 1 : 80 homogeneous, and anti-SSA antibody was 6.3 AI (normal <1.0 AI). The patient was treated with prednisone 20 mg/day with marked improvement in his symptoms. Repeat chest computed tomography showed decreased groundglass opacities and decreased mediastinal lymph nodes. After more than a year, he was readmitted due to petechiae on his buccal mucosa and a platelet count of 2000/μL. The patient was started on prednisone 80 mg/d and intravenous immunoglobulin 80 g/d for 2 consecutive days. The platelet count eventually increased to 244,000/μL.
CONCLUSION: We report a rare presentation of Sjogren's syndrome manifesting as acute lymphocytic interstitial pneumonitis and followed by immune thrombocytopenia. Both extraglandular manifestations responded well to corticosteroid therapy.
Copyright © 2021 Maham Mehmood et al.

Entities:  

Year:  2021        PMID: 33791139      PMCID: PMC7984903          DOI: 10.1155/2021/6681590

Source DB:  PubMed          Journal:  Case Rep Rheumatol        ISSN: 2090-6897


  7 in total

Review 1.  Pathophysiology of immune thrombocytopenic purpura.

Authors:  D S Beardsley
Journal:  Blood Rev       Date:  2002-03       Impact factor: 8.250

Review 2.  Primary Sjögren syndrome: hematologic patterns of disease expression.

Authors:  Manuel Ramos-Casals; Jasep Font; Mario Garcia-Carrasco; Maria-Pilar Brito; Jose Rosas; Jaime Calvo-Alen; Lucio Pallares; Ricard Cervera; Miguel Ingelmo
Journal:  Medicine (Baltimore)       Date:  2002-07       Impact factor: 1.889

3.  Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements.

Authors:  Ramos-Casals Manuel; Brito-Zerón Pilar; Seror Raphaèle; Bootsma Hendrika; Bowman Simon J; Dörner Thomas; Gottenberg Jacques-Eric; Mariette Xavier; Theander Elke; Bombardieri Stefano; De Vita Salvatore; Mandl Thomas; Ng Wan-Fai; Kruize Aike; Tzioufas Athanasios; Vitali Claudio
Journal:  Rheumatology (Oxford)       Date:  2017-07-01       Impact factor: 7.580

4.  Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome.

Authors:  Raphaèle Seror; Christelle Sordet; Loic Guillevin; Eric Hachulla; Charles Masson; Marc Ittah; Sophie Candon; Véronique Le Guern; Achille Aouba; Jean Sibilia; Jacques-Eric Gottenberg; Xavier Mariette
Journal:  Ann Rheum Dis       Date:  2006-09-01       Impact factor: 19.103

Review 5.  Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis.

Authors:  Baodong Qin; Jiaqi Wang; Zaixing Yang; Min Yang; Ning Ma; Fenglou Huang; Renqian Zhong
Journal:  Ann Rheum Dis       Date:  2014-06-17       Impact factor: 19.103

6.  2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts.

Authors:  Caroline H Shiboski; Stephen C Shiboski; Raphaèle Seror; Lindsey A Criswell; Marc Labetoulle; Thomas M Lietman; Astrid Rasmussen; Hal Scofield; Claudio Vitali; Simon J Bowman; Xavier Mariette
Journal:  Arthritis Rheumatol       Date:  2016-10-26       Impact factor: 10.995

Review 7.  2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus.

Authors:  Martin Aringer; Karen Costenbader; David Daikh; Ralph Brinks; Marta Mosca; Rosalind Ramsey-Goldman; Josef S Smolen; David Wofsy; Dimitrios T Boumpas; Diane L Kamen; David Jayne; Ricard Cervera; Nathalie Costedoat-Chalumeau; Betty Diamond; Dafna D Gladman; Bevra Hahn; Falk Hiepe; Søren Jacobsen; Dinesh Khanna; Kirsten Lerstrøm; Elena Massarotti; Joseph McCune; Guillermo Ruiz-Irastorza; Jorge Sanchez-Guerrero; Matthias Schneider; Murray Urowitz; George Bertsias; Bimba F Hoyer; Nicolai Leuchten; Chiara Tani; Sara K Tedeschi; Zahi Touma; Gabriela Schmajuk; Branimir Anic; Florence Assan; Tak Mao Chan; Ann Elaine Clarke; Mary K Crow; László Czirják; Andrea Doria; Winfried Graninger; Bernadett Halda-Kiss; Sarfaraz Hasni; Peter M Izmirly; Michelle Jung; Gábor Kumánovics; Xavier Mariette; Ivan Padjen; José M Pego-Reigosa; Juanita Romero-Diaz; Íñigo Rúa-Figueroa Fernández; Raphaèle Seror; Georg H Stummvoll; Yoshiya Tanaka; Maria G Tektonidou; Carlos Vasconcelos; Edward M Vital; Daniel J Wallace; Sule Yavuz; Pier Luigi Meroni; Marvin J Fritzler; Ray Naden; Thomas Dörner; Sindhu R Johnson
Journal:  Ann Rheum Dis       Date:  2019-08-05       Impact factor: 27.973

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.